Sari Riihijärvi

Sari Riihijärvi serves as the Chief Medical Officer at Pihlajalinna since July 2021, previously holding key positions at Terveystalo, including VP Clinical Development and Value-Based Healthcare and Director of Clinical Services from February 2014 to November 2020. Sari has a background in research as part of the Biomedicum Helsinki Genome-scale Biology Program, with involvement in the Leppä Group from September 2008 to October 2016. Additionally, Sari served as a clinical lecturer at the University of Helsinki in 2015 and worked as a medical doctor specializing in medical oncology and radiation therapy at Docrates Cancer Center and the Hospital District of Helsinki and Uusimaa from 2006 to 2014. Education includes a Doctor of Medicine PhD from the University of Helsinki, alongside specialization in medical oncology and a degree from the University of Tampere.